We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601127:SSESeres Group Co. Ltd. Class A Analysis

Data as of 2026-09-01 - not real-time

CN¥50.55

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Seres Group Co.,Ltd is bearish at ¥50.55, with short-term averages lagging the long-term ones. It has lost 8.9% over the past 30 days. With RSI at 36.9 the momentum picture is approaching oversold, alongside a bullish MACD signal. Recent trading has carved out support near ¥49.19 and resistance around ¥59.91.
On valuation the read is fair — an earnings multiple of 62.4, absent a reliable peer benchmark. Sell-side targets cluster 44.5% above the current quote. Revenue is contracting at 26.6% on a 0.8% profit margin. The 2.24% dividend yield looks stretched against payout coverage.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 35.5%, a beta of 0.29 and a maximum drawdown of 71.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.

Top Market Events

HONG KONG, Apr 10, 2026 - ACN Newswire - In 2025, sales of traditional premium ICE vehicles fell by approximately 46%...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 91.75
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Dividend yield of 2.24% looks stretched against payout coverage
  • Trading below the 200-day average of 91.75

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Dividend yield of 2.24% looks stretched against payout coverage
  • Analyst targets imply +44.5% versus the current price
  • Revenue contracting at -26.6%

Key Metrics & Analysis

Financial Health

Revenue Growth-26.60%
Profit Margin0.81%
P/E Ratio62.4
ROE2.59%
ROA1.03%
Debt/Equity12.35
P/B Ratio2.3
Op. Cash FlowCN¥2.1B
Free Cash FlowCN¥3.2B

Technical Analysis

TrendBearish
RSI36.9
SupportCN¥49.19
ResistanceCN¥59.91
MA 20CN¥52.86
MA 50CN¥56.14
MA 200CN¥91.75
MACDBullish
VolumeDecreasing
Fear & Greed Index94.71

Valuation

Fair ValueCN¥62.38
Target PriceCN¥73.02
Upside/Downside44.46%
GradeFair
TypeBlend
Dividend Yield2.24%

Risk Assessment

Beta0.29
Volatility35.46%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.